United Against Cancer

News from the LSU LCMC Health Cancer Center 

LSU LCMC Health Cancer Center Researchers Receive $3.1 Million NIH Grant for Pancreatic Cancer Research


LSU Health New Orleans has received a five-year, $3.1 million NIH grant to advance pancreatic cancer research led by LSU LCMC Health Cancer Center investigators Drs. Samarpan Majumder and Rinku Majumder.


The project received a rare perfect NIH impact score of 10 and will explore how Protein S influences tumor growth and cancer-associated blood clotting. The goal is to identify new therapeutic strategies addressing two major causes of pancreatic cancer mortality.


This historic award is the first NIH R01 for pancreatic cancer led by a Louisiana investigator since the mid-1980s and the first ever at LSU Health New Orleans and strengthens Louisiana’s capacity to confront one of its deadliest cancers.


Read more about the research and the team behind it: https://www.medschool.lsuhsc.edu/cancer_center/newsroom/nih_grant_for_pancreatic_cancer.aspx

LSU Engineering Students Advance Breast Cancer Research 


A team of LSU Biological Engineering seniors is developing an innovative microfluidic device that could improve how researchers study triple-negative breast cancer and evaluate potential treatments.

The device recreates a more realistic environment for growing cancer cells and allows researchers to continuously monitor how the cells respond to chemotherapy without interrupting the experiment.


The project brings together engineering, biology and medical research to address an aggressive form of breast cancer with particular relevance for Louisiana communities.


Read more about the students, their technology and the collaborative research behind it: https://www.lsu.edu/eng/news-stories/2026/06/lsu-be-students-advance-breast-cancer-research.php

Cancer Center Members Advance Prostate Cancer Risk Prediction


Congratulations to LSU LCMC Health Cancer Center members Dr. Hui-Yi Lin, Indrani Sarkar and Harun Mazumder, and team on their recently published research in Communications Medicine.


The team developed a new genetic risk score designed to better predict whether prostate cancer is likely to be aggressive. Using data from more than 40,000 patients across three large datasets, the new model outperformed existing risk scores and more effectively identified patients at the highest risk for aggressive disease. The findings could ultimately help guide earlier screening, prevention and more personalized clinical care.


Read the full study:https://www.nature.com/articles/s43856-026-01645-z?utm_source=chatgpt.com

There's still time to Join Us for Teal Tea!

The annual Teal Tea Luncheon supporting LSU Health New Orleans' section of Gynecologic Oncology will be held on Wednesday, Sept. 16.


This luncheon supports the areas of greatest need for Gynecologic Oncology, such as:

  • To support patients as they pursue cancer care, especially underserved women
  • To support scientific discovery through high-quality cancer research
  • To promote a culture of learning, yielding the highest quality women’s health providers for years to come 


Tickets can be purchased by visiting https://my.onecause.com/event/organizations/sf-001C000001foTTBIA2/events/vevt:0ceda6fa-3d27-4eec-b1d0-22dbfcefc65e/home/story

About Us - The LSU LCMC Health Cancer Center advances the fight against cancer through an integrated approach that brings together innovative research, patient-centered clinical care, and next-generation education. Research drives our mission, fueling discoveries that improve prevention, diagnosis, and treatment. In partnership with LCMC Health, our clinical teams deliver advanced, personalized cancer care to patients across Louisiana. Through the Department of Interdisciplinary Oncology at LSU Health New Orleans, we are also training the future leaders of cancer medicine and research. Together, we are expanding access to innovation and improving outcomes for the communities we serve.


Learn more: lsulcmchealthcancercenter.org